HEALTHSTORY 564· JUNE 26, 2026

BIO 2026 in San Diego Signals a Mood Shift for the Biotech Industry

BIO 2026, one of the largest annual gatherings of biotechnology companies and investors, brought delegations from dozens of countries to San Diego and delivered something the industry had not felt at several comparable events in the prior…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 563Decoy Therapeutics Raises Up to $21 Million in Private Placement to Fund Novel Antiviral Platform NEXT STORY 565 →U.S. Strikes Iran as Trump Cites Ceasefire Violation in Strait of Hormuz

Keep reading

More from the desk.

24HEALTH

Seven months after launch, Aurora Therapeutics scraps its lead gene-editing program and cuts staff

Personalized CRISPR therapies, gene-editing treatments built around one patient's specific mutation rather than a disease shared by millions, just lost one of their early backers. Aurora Therapeutics has scrapped its lead program and laid…

health2 MIN

39HEALTH

California Supreme Court rules Gilead Sciences has no legal duty to fast-track a safer HIV drug

Pharmaceutical companies do not owe patients a legal duty to speed up development of a safer drug simply because a less safe version is already on the market. That concept, called a "duty to innovate," was at the center of a case brought…

health2 MIN

50HEALTH

Trump administration shifts 340B drug program from upfront discounts to rebates, drawing hospital backlash

A federal law requires pharmaceutical manufacturers to sell discounted medicines to specific hospitals and clinics. That discount mechanism, the foundation of the 340B Drug Pricing Program, is now being reshaped. The Trump administration…

health2 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk